2m 2m 2m 2m 2m 2m 2m
NAUTILUS BIOTECH (NAUT)
NASDAQ
$2.11+$0.53 (+34.08%)
Price as of Oct 02, 2026 5:35 PM EDT- $199.8MMarket Cap
- 80.65%1-Year Change
- BiotechnologyIndustry
NAUTILUS BIOTECH (NAUT)
$2.11+$0.53 (+34.08%)
NAUT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.57 | ||
Change | +$0.15 (+10.56%) | ||
Open | $1.43 | ||
High | $1.68 | ||
Low | $1.38 | ||
Previous Close | $1.42 | ||
Volume | 8,507,794 | ||
30-Day Average Volume | 3,046,739 | ||
1-Week Change | 58.51% | ||
1-Month Change | 69.45% | ||
1-Year Change | 80.65% | ||
3-Year Change | -50.32% | ||
5-Year Change | -74.72% | ||
Fundamentals | |||
Shares Outstanding | 127.3M | ||
Total Assets | $163.6M | ||
Market Cap | $199.8M | ||
Enterprise Value | $186.6M | ||
Period: QTR TTM FY | |||
Revenue | $180,000.00 | ||
Net Income | -$14.5M | ||
Free Cash Flow | -$14.2M | ||
EBIT | -$14.5M | ||
EBITDA | -$14.2M | ||
Net Working Capital | $79.0M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 1,037 | ||
P/B | 2 | ||
P/E | -14 | ||
PEG | -2 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue